Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700